tidytlg
A tables-listings-graphs package that reached CRAN and then went quiet.
A side-by-side editorial comparison of DoseFinding and logrx — release velocity, themes, recent moves, and the top alternatives to consider.
New stewardship at openpharma, then two releases adding the methods MCP-Mod was missing
DoseFinding implements MCP-Mod and related dose-response methodology for clinical trial design and analysis. In 2024 it changed hands — Marius Thomas took over as maintainer, Novartis was recorded as copyright holder and funder, and the package moved to the openpharma GitHub organisation with roxygen documentation and a proper NEWS file. The two releases since have added substantive methodology: model averaging for dose-response fitting in 1.3-1, and conditional and predictive power for interim analyses in 1.4-1.
A clinical-script logger that stopped shipping after its 0.2 line, changelogs made of merged PRs.
logrx produces execution logs for R scripts in regulated clinical work, recording what ran, what it returned, and which unapproved packages or functions were used. Its release notes are raw merged-PR lists rather than written changelogs, which makes the substance hard to read from the feed. The most recent release, 0.2.2 in June 2023, exists to track tidyselect and dplyr changes.
DoseFinding implements MCP-Mod and related dose-response methodology for clinical trial design and analysis. In 2024 it changed hands — Marius Thomas took over as maintainer, Novartis was recorded as copyright holder and funder, and the package moved to the openpharma GitHub organisation with roxygen documentation and a proper NEWS file. The two releases since have added substantive methodology: model averaging for dose-response fitting in 1.3-1, and conditional and predictive power for interim analyses in 1.4-1.
The pattern before the handover was maintenance — R-devel compliance, a bug fix, a link. After it, each release carries a named methodological addition with an acknowledged contributor, plus documentation to match: a longitudinal analysis vignette shipped alongside the interim power work. Housekeeping continues underneath, mostly clearing deprecated ggplot2 interfaces, aes_string in one release and qplot in the next.
Given the last two releases each added one method with a supporting vignette, expect the next to follow the same shape. Both additions so far extend the package beyond fixed dose-response fitting, so adaptive and interim methodology is the more likely direction.
logrx produces execution logs for R scripts in regulated clinical work, recording what ran, what it returned, and which unapproved packages or functions were used. Its release notes are raw merged-PR lists rather than written changelogs, which makes the substance hard to read from the feed. The most recent release, 0.2.2 in June 2023, exists to track tidyselect and dplyr changes.
Feature work concentrated in the 0.1 line — return codes, a results writer, a to_report parameter, and logging of unapproved package and function use — and the 0.2 releases have been compatibility maintenance and hotfixes. Three years of silence in a pharmaverse that has otherwise kept shipping suggests the package reached the shape its users needed rather than that it was abandoned mid-design.
Nothing in these entries points to planned work; the likeliest trigger for a release is a breaking change in tidyverse dependencies, which is what produced the last one.
Other Analytics products tracked by Sparkpulse, ranked by recent ship velocity. Each card links to a full editorial trajectory and lets you pivot into a head-to-head comparison with either DoseFinding or logrx.
A tables-listings-graphs package that reached CRAN and then went quiet.
Tplyr made clinical summary tables explain where every number came from.
Clinical listings that keep inheriting their hardest problem — pagination — from the layer below.
A cache-directory helper that has shipped nothing but CRAN-triggered patches for seven years.
gigs redesigned its whole conversion API for rOpenSci, then spent three releases getting the docs to build.
A weather-data client that keeps rewriting its HTTP layer while slowly tightening its API.
See all DoseFinding alternatives → · See all logrx alternatives →
Latest ship moves from both products, interleaved chronologically. ⚡ = editorial spark.
Both compete on the same themes — clinical-trials — within Analytics. DoseFinding and logrx are shipping at a similar cadence (velocity 0.0 vs 0.0, both within Sparkpulse's "active" band). See the at-a-glance table above for a side-by-side breakdown of velocity, recent sparks, and editorial themes.
Sparkpulse doesn't pick a winner — we score release velocity, not feature parity. DoseFinding and logrx are shipping at a similar cadence (velocity 0.0 vs 0.0, both within Sparkpulse's "active" band). For your specific use case, the alternatives sections above list other Analytics products to evaluate alongside.
Top DoseFinding alternatives in Analytics are ranked by recent ship velocity. Browse the "DoseFinding alternatives" section above for the current picks, or visit /alternatives/dosefinding for the full list with editorial commentary on each.
Top logrx alternatives in Analytics are ranked by recent ship velocity. Browse the "logrx alternatives" section above for the current picks, or visit /alternatives/logrx for the full list with editorial commentary on each.